Titan Pharmaの空売り状況は、投資家がTitan Pharmaの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Titan Pharma (NASDAQ:TTNP) 株価情報, 空売り情報

TITAN PHARMA INC

Titan Pharmaceuticals

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharmaceuticals Inc

Titan Pharmaceuticals Inc Warrants - Class B (18/10/2024)

U.S. stock futures rose on Monday following Friday&#8217;s advances. Futures of major benchmark indices were higher in premarket.
President Donald Trump on Friday temporarily <a href="https://benzinga.com/25/04/44778464/trump-administration-grants-tariff-reprieve-to-tech-industry-apple-and-nvidia-among-beneficiaries">exempted smartphones, computers, and chips</a> from new U.S. reciprocal tariffs, despite a 20% tariff remaining on all Chinese goods, reversing part of a recently imposed 145% tariff.
However, the Commerce Secretary Howard Lutnick indicated these <a href="https://www.benzinga.com/general/market-summary/25/04/44783093/mark-cuban-examines-trumps-tariff-exemptions-rationale-on-electronics-thats-billions-of-revenue-for-the-usa">electronics exemptions are temporary</a>, and further tariffs could follow soon. Investors also assessed the upbeat bank earnings and cooler-than-expected inflation data.
The 10-year Treasury bond yielded 4.46% and the two-year bond was at 3.92%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool&#8217;s </a>projections show markets pricing a 79.3% likelihood of the Federal Reserve keeping the current interest rates unchanged in its May meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>1.00%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>1.44%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>1.69%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.95%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Monday. The SPY was up 1.47% to $541.71, while the QQQ advanced 1.75% to $462.35, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
U.S. stocks finished Friday&#8217;s session higher, fuelled by robust bank earnings from JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) and Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), alongside surprisingly cooler producer inflation data up 2.7% year-on-year in March, down by 0.4% monthly.
All S&amp;P 500 sectors saw gains, with energy, information technology, and materials stocks leading the advance.
The positive sentiment resulted in significant weekly gains for the major averages: the S&amp;P 500 rose 5.7%, its best week since November 2023, the Nasdaq surged 7.3%, its best week since November 2022, and the Dow climbed approximately 5%.
The Dow Jones index climbed 619 points or 1.56% to 40,212.71, whereas the S&amp;P 500 index advanced 1.81% to 5,363.36. Nasdaq Composite rose to end 2.06% higher at 16,724.46, and the small-cap gauge, Russell 2000, jumped 1.57% to 1,860.20.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>2.06%</td>
<td>16,724.46</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>1.81%</td>
<td>5,363.36</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>1.56%</td>
<td>40,212.71</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.57%</td>
<td>1,860.20</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
According to Louis Navellier of Navellier &amp; Associates, given the severe selling in the stock market and high trading volume, &#8220;it appears that much of the selling pressure is starting to be exhausted.&#8221;
&#8220;There is no doubt that there will be ripple effects from the Trump Administration's trade war with China. It is imperative that the velocity of money picks up if news breaks on tariffs diminishing and/or the Fed cutting key interest rates,&#8221; he added.
Amid the growing trade tensions between the U.S. and China, Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) cut its targets for key Chinese stock indexes for a second time this month.
According <a href="https://www.bloomberg.com/news/articles/2025-04-14/goldman-sachs-cuts-targets-for-china-stocks-second-time-in-april#:~:text=The%20Goldman%20team%20trimmed%20its,to%20soften%20the%20trade%20shock.">to</a> Bloomberg, "U.S.-China trade tensions have soared to unprecedented levels, prompting concerns about global recession, and decoupling risks between the two largest economies globally in other strategic cohorts, notably capital markets, technology, and geopolitics," a team led by Kinger Lau wrote in a note Monday. 
Analysts reduced 12-month price targets for the MSCI China Index to 75 from 81 and the CSI 300 Index to 4,300 from 4,500 points, suggesting potential gains of 12% and 15% respectively based on Friday&#8217;s closing prices.
Meanwhile, Wedbush Securities&#8217; Dan Ives described the exclusion of smartphones and chips from China tariffs as the &#8220;dream scenario&#8221; for tech investors, stating that it&#8217;s a &#8220;game changer.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">"This is the dream scenario for tech investors," Dan Ives, global head of technology research at Wedbush Securities, told CNBC. "Smartphones, chips being excluded is a game changer scenario when it comes to China tariffs." <a href="https://twitter.com/CNBC?ref_src=twsrc%5Etfw">@CNBC</a> &#x1f3c6;&#x1f402;&#x1f525;&#x1f447;<a href="https://t.co/BhVWX2IYyN">https://t.co/BhVWX2IYyN</a>
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1911066705406685306?ref_src=twsrc%5Etfw">April 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on this week:
<ul>
<li>On Monday, Philadelphia Fed President Patrick Harker will speak at 6:00 p.m., and Atlanta Fed President Raphael Bostic will speak at 7:40 p.m. ET.</li>
</ul>
<ul>
<li>On Tuesday, March&#8217;s import price index data and April&#8217;s Empire State manufacturing survey data will be released by 8:30 a.m. ET.</li>
</ul>
<ul>
<li>On Wednesday, March&#8217;s U.S. retail sales will be out by 8:30 a.m. ET.</li>
</ul>
<ul>
<li>Industrial production and capacity utilization data for March will be announced at 9:15 a.m. ET.</li>
</ul>
<ul>
<li>Business inventories for February and the home builder confidence index for April will be out by 10:00 a.m. ET.</li>
</ul>
<ul>
<li>Cleveland Fed President Beth Hammack will speak at 12:00 p.m. ET.</li>
</ul>
<ul>
<li>On Thursday, initial jobless claims data for the week ending April 12 and March&#8217;s housing starts, building permits, and April&#8217;s Philadelphia Fed manufacturing survey data will be released by 8:30 a.m. ET.</li>
</ul>
<ul>
<li>On Friday, San Francisco Fed President Mary Daly will speak at 8:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) was up 1.73% in premarket on Monday as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $12.35 per share on revenue of $14.81 billion.</li>
</ul>
<ul>
<li>M&amp;T Bank Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) jumped 4.15% as Wall Street expects it to report earnings of $3.40 per share on revenue of $2.34 billion before the opening bell.</li>
</ul>
<ul>
<li>Pinnacle Financial Partners Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNFP#NASDAQ">PNFP</a>) was 0.16% lower as it is expected to report earnings after the closing bell. Analysts expect a quarterly earnings of $1.80 per share on revenue of $483.71 million.</li>
</ul>
<ul>
<li>Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) was up 0.27% after it announced a $1 million private placement consisting of convertible preferred stock.</li>
</ul>
<ul>
<li>Aon PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) advanced 0.24% after announcing a 10% increase to its quarterly cash dividend.</li>
</ul>
<ul>
<li>Synaptics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYNA#NASDAQ">SYNA</a>) was 0.82% higher after unveiling its next-generation touch controller engineered for foldable OLED displays.</li>
</ul>
<ul>
<li>BP PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) jumped 2.75% after announcing an oil discovery at the Far South prospect in the deepwater U.S. Gulf of America.</li>
</ul>
<ul>
<li>Sony Group Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) rose 1.79% after increasing the PS5&#8217;s price in Europe by 25%, ahead of a likely U.S. hike.</li>
</ul>
<ul>
<li>Chipmakers Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) gained 2.35%, Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) was up 0.59%, Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) was 1.82% higher and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) jumped 2.28% after Trump announced the he would levy tariff rate on imported semiconductors this week, adding that there would be flexibility with some companies in the sector.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 0.78% to hover around $61.98 per barrel.
Gold Spot US Dollar declined 0.32% to hover around $3,229.62 per ounce. Its fresh record high stood at $3,245.76 per ounce. The U.S. Dollar Index spot was lower by 0.66% at the 99.439 level.
Asian markets rose on Monday, including India's S&amp;P BSE Sensex, China&#8217;s CSI 300, Hong Kong's Hang Seng, Japan's Nikkei 225, Australia's ASX 200, and South Korea's Kospi index. European markets were mostly higher in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/04/44783093/mark-cuban-examines-trumps-tariff-exemptions-rationale-on-electronics-thats-billions-of-revenue-for-the-usa">Mark Cuban Examines Trump&#8217;s Tariff Exemptions Rationale On Electronics: &#8216;That&#8217;s Billions Of Revenue For The USA&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Market Summary

News

Futures

Commodities

Treasuries

Economics

Federal Reserve

Pre-Market Outlook

Markets

AVGO

NVDA

PNFP

Sony Group Corporation American Depositary Shares

SONY

SYNA

TTNP

US Stocks Likely To Open Higher: Expert Says 'The Selling Pressure Is Starting To Be Exhausted'

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects The Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) to report quarterly earnings at $12.35 per share on revenue of $14.81 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Goldman Sachs shares rose 1.1% to $499.80 in after-hours trading.</li>
<li>Titan Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) announced a $1 million private placement consisting of convertible preferred stock. Titan Pharmaceuticals shares jumped 9% to $4.00 in the after-hours trading session.</li>
<li>Analysts are expecting M&amp;T Bank Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) to post quarterly earnings at $3.40 per share on revenue of $2.34 billion. The company will release earnings before the markets open. M&amp;T Bank shares fell 1.7% to $155.34 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) announced a 10% increase to its quarterly cash dividend. The company raised its quarterly dividend from 67.5 cents to 74.5 cents per share. Aon shares rose 0.1% to $376.50 in the after-hours trading session.</li>
<li>Analysts expect Pinnacle Financial Partners Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNFP#NASDAQ">PNFP</a>) to post quarterly earnings at $1.80 per share on revenue of $483.71 million after the closing bell. Pinnacle Financial Partners shares gained 0.6% to $90.58 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/04/44759831/top-3-industrials-stocks-that-may-explode-in-april">Top 3 Industrials Stocks That May Explode In April</a> </li>
</ul>
Photo via Shutterstock

Earnings

Trading Ideas

Goldman Sachs, M&T Bank And 3 Stocks To Watch Heading Into Monday

<h3>Gainers</h3>
<ul>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) shares rose 15.3% to $0.52 during Friday's after-market session. The market value of their outstanding shares is at $14.5 million. </li>
<li>Wellgistics Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGRX#NASDAQ">WGRX</a>) stock rose 14.18% to $3.3. The market value of their outstanding shares is at $171.4 million. </li>
<li>Aclarion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) stock rose 11.52% to $9.29. The company's market cap stands at $4.7 million. As per the news, the Q4 earnings report came out 2 days ago. </li>
<li>180 Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) stock increased by 10.95% to $0.95. The company's market cap stands at $3.6 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) stock rose 10.8% to $4.0. The company's market cap stands at $3.6 million. </li>
<li>Radiopharm Theranostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RADX#NASDAQ">RADX</a>) stock increased by 10.11% to $4.9. The market value of their outstanding shares is at $38.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Longevity Health Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) shares decreased by 18.5% to $0.11 during Friday's after-market session. The market value of their outstanding shares is at $3.3 million. </li>
<li>Climb Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLYM#NASDAQ">CLYM</a>) shares declined by 11.72% to $1.13. The company's market cap stands at $76.2 million. </li>
<li>Citius Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) shares decreased by 8.97% to $0.61. The market value of their outstanding shares is at $43.7 million. </li>
<li>Virax Biolabs Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAX#NASDAQ">VRAX</a>) stock declined by 7.28% to $1.02. The market value of their outstanding shares is at $4.4 million. </li>
<li>Pasithea Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) stock fell 7.05% to $1.32. The company's market cap stands at $3.5 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) shares decreased by 6.67% to $2.03. The company's market cap stands at $6.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ACON

ATNF

CLYM

CTOR

KTTA

ONMD

RADX

SNGX

VRAX

WGRX

Longevity Health Holdings, Inc. - Common Stock

XAGE

12 Health Care Stocks Moving In Friday's After-Market Session

WIIM

Titan Pharmaceuticals shares are trading higher after the company announced a $1 million private placement consisting of convertible preferred stocks.

General

Titan Pharmaceuticals Reveals $1M Private Placement Of Convertible Preferred Stock

<h3>Gainers</h3>
<ul>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) shares rose 83.4% to $0.52 during Wednesday's pre-market session. The company's market cap stands at $7.1 million. </li>
<li>Pasithea Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) shares moved upwards by 71.63% to $3.57. The company's market cap stands at $4.5 million. </li>
<li>Mainz Biomed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNZ#NASDAQ">MYNZ</a>) stock moved upwards by 17.14% to $8.2. The market value of their outstanding shares is at $18.2 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares moved upwards by 14.46% to $3.72. The company's market cap stands at $3.4 million. </li>
<li>SenesTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNES#NASDAQ">SNES</a>) stock moved upwards by 11.88% to $3.39. The market value of their outstanding shares is at $3.5 million. </li>
<li>Nanoviricides (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NNVC#AMEX">NNVC</a>) shares moved upwards by 11.75% to $1.27. The market value of their outstanding shares is at $18.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Nuvectis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCT#NASDAQ">NVCT</a>) stock fell 14.3% to $6.0 during Wednesday's pre-market session. The company's market cap stands at $115.9 million. </li>
<li>EyePoint Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) stock declined by 14.18% to $6.54. The market value of their outstanding shares is at $446.3 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares fell 14.01% to $0.23. The company's market cap stands at $2.0 million. </li>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) stock fell 13.59% to $0.28. The company's market cap stands at $3.4 million. </li>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) shares declined by 10.4% to $2.93. The company's market cap stands at $18.3 million. </li>
<li>HCW Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCWB#NASDAQ">HCWB</a>) shares fell 9.95% to $0.49. The company's market cap stands at $21.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AZTR

EVAX

EYPT

HCWB

MYNZ

NNVC

NVCT

OGEN

SNES

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Under Nasdaq rules, the Company has 60 calendar days from receipt of the 5250 Notice or until January 21, 2025, to submit a plan to regain compliance with the Listing Rule.&nbsp;

Titan Pharmaceuticals Gets Non-Compliance Notice From Nasdaq

U.S. stocks traded mostly lower toward the end of trading, with the S&amp;P 500 falling around 0.1% on Tuesday.
The Dow traded down 0.12% to 40,849.39 while the NASDAQ fell 0.11% to 17,856.43. The S&amp;P 500 also fell, dropping, 0.07% to 5,604.36.
Check This Out: <a href="https://www.benzinga.com/news/24/08/40460726/apple-alphabet-and-2-other-stocks-insiders-are-selling">Apple, Alphabet And 2 Other Stocks Insiders Are Selling</a>
Leading and Lagging Sectors Health care shares climbed by 0.4% on Tuesday.
In trading on Tuesday, energy shares fell by 2.4%.
Top Headline
Shares of Palo Alto Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) gained around 9% on Tuesday after the company reported better-than-expected results for its fourth quarter and issued strong guidance.
Palo Alto&#8217;s board authorized an additional $500 million for share repurchases, bringing the company&#8217;s remaining buyback authorization up to $1 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>InMed Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INM#NASDAQ">INM</a>) shares shot up 194% to $0.4361 after the company announced that INM-901 will be used in its development programs for Alzheimer&#8217;s Disease.</li>
<li>Shares of Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) got a boost, surging 17% to $3.4850 after the company reported better-than-expected second-quarter sales results. Also, the company announced a binding term sheet with Boosteroid.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares were also up, gaining 94% to $9.71. Titan Pharmaceuticals entered into merger and contribution and share exchange agreement regarding a business combination with KE Sdn. Bhd.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares dropped 54% to $1.92 after the company cut its FY24 revenue guidance.</li>
<li>Shares of ATRenew Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NASDAQ">RERE</a>) were down 13% to $2.46 following second-quarter results.</li>
<li>Vipshop Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) was down, falling 17% to $11.60 after the company reported second-quarter results and guided third-quarter revenues down approximately 5-10%.</li>
</ul>
Commodities In commodity news, oil traded down 0.7% to $73.82 while gold traded up 0.5% at $2,553.30.
Silver traded up 0.5% to $29.46 on Tuesday, while copper fell 0.8% to $4.1490.
Euro zone
European shares closed lower today. The eurozone's STOXX 600 slipped 0.45%, Germany's DAX fell 0.35% and France's CAC 40 slipped 0.22%. Spain's IBEX 35 Index fell 0.13%, while London's FTSE 100 fell 1%.
The annual inflation rate in the Eurozone increased to 2.6% in July from 2.5% in the prior month, while current account surplus rose to €52.4 billion in June from €32.4 billion a year ago. Italy&#8217;s current account surplus widened to EUR 4,885 billion in June from EUR 1,248 billion in the year-ago period. Producer prices in Germany fell by 0.8% year-over-year in July.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 gaining 1.80%, Hong Kong's Hang Seng Index falling 0.33%, China's Shanghai Composite Index falling 0.93% and India's BSE Sensex rising 0.47%.
The annual inflation rate in Hong Kong increased to 2.5% in July from 1.5% in the prior month. The People&#8217;s Bank of China kept key lending rates unchanged at the recent fixing.
Economics
No major economic reports are scheduled for release today.
Now Read This:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40461302/top-3-tech-stocks-which-could-rescue-your-portfolio-this-quarter"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40461302/top-3-tech-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>

Eurozone

Intraday Update

BTBT

MYNA

PANW

RERE

VIPS

Crude Oil Falls; Palo Alto Networks Shares Jump After Q4 Earnings

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Tuesday.
The Dow traded down 0.10% to 40,854.31 while the NASDAQ fell 0.15% to 17,850.34. The S&amp;P 500 also fell, dropping, 0.06% to 5,604.70.
Check This Out: <a href="https://www.benzinga.com/news/24/08/40460726/apple-alphabet-and-2-other-stocks-insiders-are-selling">Apple, Alphabet And 2 Other Stocks Insiders Are Selling</a>
Leading and Lagging Sectors Health care shares climbed by 0.5% on Tuesday.
In trading on Tuesday, energy shares fell by 1%.
Top Headline
Medtronic Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) reported better-than-expected results for its first quarter on Tuesday.
The company posted first-quarter 2025 sales of $7.92 billion, beating the consensus of $7.89 billion. The medical device maker reported adjusted EPS of $1.23, beating the consensus of $1.20. Revenue increased 2.8% year over year, as reported, and 5.3% organic.
Medtronic revised its fiscal year 2025 adjusted EPS guidance to $5.42 – $5.50, compared to prior guidance of $5.40 – $5.50 and consensus of $5.44. The company sees fiscal year 2025 organic revenue growth of 4.5% – 5% compared to prior guidance of 4% – 5%.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>InMed Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INM#NASDAQ">INM</a>) shares shot up 250% to $0.5075 after the company announced that INM-901 will be used in its development programs for Alzheimer&#8217;s Disease.</li>
<li>Shares of Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) got a boost, surging 16% to $3.47 after the company reported better-than-expected second-quarter sales results. Also, the company announced a binding term sheet with Boosteroid.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares were also up, gaining 108% to $10.37. Titan Pharmaceuticals entered into merger and contribution and share exchange agreement regarding a business combination with KE Sdn. Bhd.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares dropped 54% to $1.93 after the company cut its FY24 revenue guidance.</li>
<li>Shares of ATRenew Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NASDAQ">RERE</a>) were down 12% to $2.5066 following second-quarter results.</li>
<li>Vipshop Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) was down, falling 10% to $12.57 after the company reported second-quarter results and guided third-quarter revenues down approximately 5-10%.</li>
</ul>
Commodities In commodity news, oil traded up 0.8% to $74.96 while gold traded up 1.1% at $2,568.90.
Silver traded up 2% to $29.875 on Tuesday, while copper rose 0.2% to $4.1875.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 slipped 0.22%, Germany's DAX fell 0.09% and France's CAC 40 slipped 0.01%. Spain's IBEX 35 Index fell 0.32%, while London's FTSE 100 fell 0.85%.
The annual inflation rate in the Eurozone increased to 2.6% in July from 2.5% in the prior month, while current account surplus rose to €52.4 billion in June from €32.4 billion a year ago. Italy&#8217;s current account surplus widened to EUR 4,885 billion in June from EUR 1,248 billion in the year-ago period. Producer prices in Germany fell by 0.8% year-over-year in July.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 gaining 1.80%, Hong Kong's Hang Seng Index falling 0.33%, China's Shanghai Composite Index falling 0.93% and India's BSE Sensex rising 0.47%.
The annual inflation rate in Hong Kong increased to 2.5% in July from 1.5% in the prior month. The People&#8217;s Bank of China kept key lending rates unchanged at the recent fixing.
Economics
No major economic reports are scheduled for release today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40461302/top-3-tech-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>

Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings

Titan Pharmaceuticals Inc Shares Resume Trade

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 80 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.19% to 40,818.40 while the NASDAQ rose 0.05% to 17,884.96. The S&amp;P 500 also rose, gaining, 0.01% to 5,609.04.
Check This Out: <a href="https://www.benzinga.com/news/24/08/40460726/apple-alphabet-and-2-other-stocks-insiders-are-selling">Apple, Alphabet And 2 Other Stocks Insiders Are Selling</a>
Leading and Lagging Sectors Health care shares climbed by 0.5% on Tuesday.
In trading on Tuesday, energy shares fell by 0.6%.
Top Headline
Lowe's Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) reported stronger-than-expected second-quarter earnings, but revealed a decline in comparable sales and revised its FY24 outlook downward.
The company reported adjusted earnings per share of $4.10, beating the analyst consensus of $3.99. Quarterly revenues totaled $23.586 billion, missing the street view of $24.013 billion.
Lowe's revised its FY24 outlook, citing lower-than-expected DIY sales and a pressured macroeconomic environment. The company now projects total sales between $82.7 billion and $83.2 billion, down from the previous range of $84 billion to $85 billion ($84.481 billion estimate). Adjusted EPS is projected to be between $11.70 and $11.90 (estimate: $12.22), compared to the earlier range of $12.00 to $12.30.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>InMed Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INM#NASDAQ">INM</a>) shares shot up 338% to $0.6730 after the company announced that INM-901 will be used in its development programs for Alzheimer&#8217;s Disease.</li>
<li>Shares of Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) got a boost, surging 224% to $1.88. Treasure Global recently submitted request to withdraw S-1 registration statement.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares were also up, gaining 108% to $10.40. Titan Pharmaceuticals entered into merger and contribution and share exchange agreement regarding a business combination with KE Sdn. Bhd.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares dropped 55% to $1.8999 after the company cut its FY24 revenue guidance.</li>
<li>Shares of ENDRA Life Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>) were down 41% to $0.9532. ENDRA Life Sciences recently announced a 1-for-50 reverse stock split.</li>
<li>BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) was down, falling 31% to $0.2251.</li>
</ul>
Commodities In commodity news, oil traded down 0.3% to $74.16 while gold traded up 1% at $2,567.50.
Silver traded up 2.2% to $29.955 on Tuesday, while copper rose 0.5% to $4.2015.
Euro zone
European shares were lower today. The eurozone's STOXX 600 slipped 0.3%, Germany's DAX fell 0.2% and France's CAC 40 slipped 0.1%. Spain's IBEX 35 Index fell 0.3%, while London's FTSE 100 fell 0.9%.
The annual inflation rate in the Eurozone increased to 2.6% in July from 2.5% in the prior month, while current account surplus rose to €52.4 billion in June from €32.4 billion a year ago. Italy&#8217;s current account surplus widened to EUR 4,885 billion in June from EUR 1,248 billion in the year-ago period. Producer prices in Germany fell by 0.8% year-over-year in July.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 gaining 1.80%, Hong Kong's Hang Seng Index falling 0.33%, China's Shanghai Composite Index falling 0.93% and India's BSE Sensex rising 0.47%.
The annual inflation rate in Hong Kong increased to 2.5% in July from 1.5% in the prior month. The People&#8217;s Bank of China kept key lending rates unchanged at the recent fixing.
Economics
No major economic reports are scheduled for release today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40461302/top-3-tech-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>

NDRA

US Stocks Mixed; Lowe's Cuts FY24 Forecast

Titan Pharmaceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 87.0%

Titan Pharmaceuticals Shares Resume Trade

PANW: 5% &#x7C; <a href="https://www.benzinga.com//node/40457641">Palo Alto Networks shares are trading higher following better-than-expected Q4 financial results, issued strong guidance and authorized an additional $500 million for repurchase. Multiple analysts raised their price targets on the stock following the report.</a>
&nbsp;
TTNP: 141% &#x7C; <a href="https://www.benzinga.com//node/40449062">Titan Pharmaceuticals Enters Merger And Contribution And Share Exchange Agreement Regarding A Business Combination With KE Sdn. Bhd.</a>
&nbsp;
AUUD: 162% &#x7C; <a href="https://www.benzinga.com//node/40457688">Auddia Inc. Announces The Launch Of faidr 3.1</a>

AUUD

Market-Moving News for August 20th

Shares of Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter sales results. Also, the company announced a binding <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40450880/bit-digital-reports-mixed-q2-results-eps-miss-revenue-up-80">term sheet with Boosteroid.</a>
Bit Digital reported quarterly losses of nine cents per share, which missed the analyst consensus estimate of losses of three cents per share. Quarterly revenue came in at $29 million, beating the analyst consensus estimate of $26.09 million by 11.16% and representing a 220.87% increase year-over-year.
Bit Digital shares jumped 11% to $3.32 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) rose 122.4% to $1.29 in today's pre-market trading. Treasure Global recently submitted request to withdraw S-1 registration statement.</li>
<li>Heramba Electric plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PITA#NASDAQ">PITA</a>) gained 127% to $4.76 in pre-market trading after jumping around 10% on Monday.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) gained 105.6% to $10.25 in pre-market trading. Titan Pharmaceuticals entered into merger and contribution and share exchange agreement regarding a business combination with KE Sdn. Bhd.</li>
<li>Tantech Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TANH#NASDAQ">TANH</a>) shares rose 60.1% to $0.2036 in pre-market trading.</li>
<li>MicroAlgo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) gained 30.5% to $0.7180 in pre-market trading after gaining around 12% on Monday.</li>
<li>MicroCloud Hologram Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) gained 28.1% to $0.5340 in pre-market trading after climbing 43% on Monday.</li>
<li>Actelis Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) gained 22.3% to $1.59 in pre-market trading after the company announced a strategic partnership with an advanced cybersecurity provider to develop and deliver a novel, AI-Powered SaaS offering, under Actelis&#8217; &#8216;Cyber Aware Networking&#8217; initiative.</li>
<li>Golden Sun Health Technology Group Limited  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSUN#NASDAQ">GSUN</a>) gained 19.1% to $6.62 in pre-market trading after dipping 25% on Monday.</li>
<li>Hawaiian Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HA#NASDAQ">HA</a>) shares gained 10.1% to $17.48 in pre-market trading. The proposed $1.9 billion merger between Alaska Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) and Hawaiian Airlines by Hawaiian Holdings has received clearance from the U.S. Justice Department, marking a significant step forward in the deal announced eight months ago. The merger is now pending approval from the U.S. Transportation Department.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Alzamend Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>) shares fell 29.1% to $4.15 in pre-market trading. Alzamend Neuro shares jumped 188% on Monday after the company announced that it is partnering with Massachusetts General Hospital as its contract research organization to conduct first of its kind Phase II clinical study of AL001 for treatment of patients with PTSD.</li>
<li>Cingulate Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CING#NASDAQ">CING</a>) shares declined 25.6% to $9.52 in pre-market trading. Cingulate shares dipped 28% on Monday after the company increased the maximum offering price for common stock under its sales agreement from $8.47 million to $11.33 million.</li>
<li>Sidus Space, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) declined 22.1% to $2.97 in pre-market trading. Sidus Space reported quarterly losses of 99 cents per share and $927,570 in revenue for the second quarter.</li>
<li>NuCana plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares fell 20.5% to $7.69 in pre-market trading. NuCana shares surged 181% on Monday after Oppenheimer reiterated an outperform rating on the stock and maintained a $150 price target, citing the company&#8217;s randomized Phase 2 trial in metastatic colorectal cancer as a key catalyst.</li>
<li>GeoVax Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) fell 18.8% to $5.80 in today's pre-market trading. On Monday, Noble Capital Markets maintained an Outperform rating on the stock and raised its price target from $6 to $10.</li>
<li>Sonder Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOND#NASDAQ">SOND</a>) fell 16.6% to $5.04 in pre-market trading. Sonder shares surged over 130% on Monday after the company announced a long-term licensing agreement with Marriott. Additionally, the company secured $146 million in additional liquidity.</li>
<li>Fluent Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNT#NASDAQ">FLNT</a>) fell 16.3% to $2.51 in pre-market trading as the company reported worse-than-expected second-quarter financial results on Monday.</li>
<li>Electra Battery Materials Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELBM#NASDAQ">ELBM</a>) shares dipped 14.2% to $0.4797 in pre-market trading. Electra Battery Materials shares surged 50% on Monday after the Department of Defense announced it awarded the company a $20 million contract to complete an industrial scale hydrometallurgical plant and establish production of cobalt sulfate.</li>
<li>Vipshop Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) shares declined 7.2% to $13.00 in pre-market trading after reporting second-quarter results.</li>
<li>ATRenew Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) shares fell 6.7% to $2.65 in pre-market trading following second-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40454461/s-p-500-nasdaq-extend-gains-for-8th-consecutive-session-investor-sentiment-improves-but-greed-index">S&amp;P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In &#8216;Fear&#8217; Zone</a></li>
</ul>

ALZN

ASNS

CING

ELBM

FLNT

GOVX

GSUN

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

MLGO

NCNA

PITA

SIDU

SOND

TANH

Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket

Trading Halt: Halt status updated at 4:35:00 PM ET: Quotation Resumption: News and Resumption Times

Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) ("Titan") today announced that it has entered into a Merger and Contribution and Share Exchange Agreement (the "Merger Agreement") regarding a business combination with KE Sdn. Bhd. ("KE"). The Merger Agreement was approved by Titan's board of directors (the "Board"). If the Merger Agreement is approved by the stockholders of Titan and KE (and the other closing conditions are satisfied or waived in accordance with the Merger Agreement), and upon consummation of the transactions contemplated by the Merger Agreement (the&nbsp;"Closing"), Titan will be combined with KE in a "reverse merger" transaction consisting of two steps: &nbsp;
<ol>
<li>TTNP Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of&nbsp;BSKE Ltd. ("BSKE"), a Cayman Islands exempted company, will merge with and into Titan (the&nbsp;"Merger"); the separate existence of Merger Sub will cease; and Titan will be the surviving corporation of the Merger and a direct wholly owned subsidiary of BSKE. 
<ol>
<li>Within five business days of the filing by Titan and BSKE of a proxy statement/prospectus relating to the proposed transaction, shareholders of KE may elect to enter into a share exchange agreement (the "Share Exchange Agreement") with Titan and BSKE, pursuant to which, immediately following the Merger, each KE shareholder entering into the Share Exchange Agreement will contribute and exchange all of his KE shares in exchange for ordinary shares of BSKE.&nbsp;Titan may terminate the Merger Agreement if fewer than all KE shareholders enter into the Share Exchange Agreement within the specified period.</li>
</ol>
</li>
</ol>

Titan Pharmaceuticals Enters Merger And Contribution And Share Exchange Agreement Regarding A Business Combination With KE Sdn. Bhd.

Trading Halt: Halted at 4:00:11 p.m. ET - Trading Halt: Halt News Pending

<h3>Gainers</h3>
<ul>
<li>CareCloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCLD#NASDAQ">CCLD</a>) stock moved upwards by 80.5% to $2.27 during Monday's regular session. The company's market cap stands at $36.6 million. </li>
<li>Novavax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) stock rose 42.17% to $12.62. The market value of their outstanding shares is at $1.7 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Macrogenics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) stock rose 27.79% to $4.23. The market value of their outstanding shares is at $264.6 million. As per the news, the Q1 earnings report came out 2 days ago. </li>
<li>Chromocell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) shares moved upwards by 25.68% to $2.3. The market value of their outstanding shares is at $13.5 million. </li>
<li>Omega Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMGA#NASDAQ">OMGA</a>) shares moved upwards by 24.01% to $2.43. The market value of their outstanding shares is at $134.0 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares increased by 21.74% to $8.4. The market value of their outstanding shares is at $7.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares declined by 40.1% to $0.84 during Monday's regular session. The company's market cap stands at $5.1 million. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) stock fell 22.03% to $2.69. The market value of their outstanding shares is at $2.3 million. The company's, Q2 earnings came out yesterday. </li>
<li>Heart Test Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSCS#NASDAQ">HSCS</a>) stock declined by 19.66% to $0.07. The company's market cap stands at $4.6 million. </li>
<li>Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) shares decreased by 16.76% to $7.7. The market value of their outstanding shares is at $65.4 million. As per the press release, Q3 earnings came out today. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) stock declined by 16.12% to $1.54. The market value of their outstanding shares is at $6.9 million. </li>
<li>Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) shares declined by 15.78% to $27.82. The company's market cap stands at $2.4 billion. The company's, Q1 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APDN

BNTC

CCLD

CHRO

FTRE

HSCS

MGNX

NVAX

OMGA

RNAZ

12 Health Care Stocks Moving In Monday's Intraday Session

Press Releases

TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

Shareholder Alert: Ademi LLP investigates whether Titan Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY, K, TTNP on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPXX, PWUP, DECA, TTNP on Behalf of Shareholders

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. - TTNP

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CFB, SDIG, TTNP on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, FRZA, TTNP on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, TTNP, FRZA on Behalf of Shareholders

Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq

Financing

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock

Comments

Titan Pharma

空売り

Titan Pharma (NASDAQ:TTNP) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル